- Email: [email protected]
Table of contents (vol. 8)
Jorrrnrrl o/ A/fiwwe
296
Dr.wrder.r. 8
(1985)296-298 Elsevier
Table of Contents (Vol. 8)
No. 1 - January/February Research
1985
Papers
Self-reported diurnal mood changes, early morning awakening and the Dexamethaaone Suppression Test in endogenous depression by L. Grunhaus. P. Flegel, B.J. Carroll and J.F. Greden (Ann Arbor, MI and Durham. NC, U.S.A.) Difficulty of follow-up and posttreatment functioning among depressed patients by A.G. Billings, R.C. Cronkite and R.H. Moos (Palo Alto, CA, U.S.A.) Bipolar II - Combine or keep separate? by J. Endicott, J. Nee, N. Andreasen, P. Clayton. M. Keller and W. Coryell (New York, NY. U.S.A.) A controlled study of a specific MAO A reversible inhibitor (Roll-1163) and amitriptyline in depressive illness by T.R. Norman. D. Ames, G.D. Burrowzs and B. Davies (Heidelberg and Parkville. Vie., Australia) Four definitions of endogenous depression and the Dexamethasone Suppression Test by M. Zimmerman, W. Coryell, B. Pfohl and D. Stangl (Iowa City. IA, U.S.A.) Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients by S.A. Simmons. P.J. Perry. E.D. Rickert and J.L. Browne (Iowa City. IA, U.S.A.) Vasoactive intestinal peptide and bipolar affective illness ~ Evidence for an effect of lithium by W.H. Berrettini, J.I. Nurnberger, P. Hotvedt, S. Simmons-Alhng and ES. Gershon (Bethesda. MD and Middlebury,VT, U.S.A.) Sleep of atypical depressives by F.M. Quitkin. J.G. Rabkin. J.W. Stewart. P.J. McGrath. W. Harrison, M. Davies, R. Goetz and J. Puig-Antich (New York. NY, U.S.A.) Apparent supersensitivity of platelet 5-HT receptors in lithium-treated patients by K. Wood. C. Swade. M.T. Abou-Saleh and A. Coppen (Epsom, U.K.) Psychosocial predictors of outcome in subjects with untreated depressive disorder by G. Parker and I. Blignault (Little Bay, NSW, Australia) The Dexamethasone Suppression Test and depressive signs in dementia by C.L.E. Katona and C.R. Adridge (London, U.K.) Reversal of vanadate-induced inhibition of Na-K ATPase ~ A possible explanation of the therapeutic effect of carbamazepine in affective illness byG.J.Naylor(Dundee,U.K.) _. _. _. _. _. The Dexamethasone Suppression Test in depression by H. Dam, E.T. Mellerup and O.J. Rafaelsen (Copenhagen, Denmark)
I-
7
Y-~ 16
17-
28
2Y- 35 37-
45
47-
53
5%
59
61-
67
69-
72
73-
Xl
x3-
89
91-
93
955103 105
No. 2 - March/April Research
1985
Paper.7
The
Dexamethasone Suppression Test in schizo-affective depression by C.L.E. Katona and M. Roth (London and Cambridge, U.K.) Mania - Diagnosis, state measurement and prediction of treatment response by S.K. Secunda. M.M. Katz, A. Swarm, S.H. Koslow, J.W. Maas. S. Chuang and J. Croughan (Springfield, Bethesda and Rockville, MD, Houston and San Antonio. TX. Chicago, IL and St. Louis. MO. U.S.A.) Plasma nortriptyline and clinical response in depression by G.E. Murphy, A.D. Simons and R.D. Wetzel (St. Louis, MO and Pittsburgh. PA, U.S.A.) Trace elements in manic depressive psychosis by G.J. Naylor, A.H.W. Smith, D. Bryce-Smith and N.1. Ward (Dundee. Reading and Ascot. U.K.) 0165-0327/85/$03.30
0 1985 Elsevier Science Publishers
B.V. (Biomedical
Division)
107-112 PA, 113-121 1233129 131-136
297 Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients - A trait finding by R.G. Kathol (Iowa City, IA, U.S.A.) . The Dexamethasone Suppression Test in delusional depression - Further findings by J.L. Ayuso-Gutierrez. M.I. Almoguera. E. Garcia-Camba, J. de1 Olmo Frias and J.A. Cabranes (Madrid, Spain) Double depression in adolescent substance users by J.H. Kashani. M.B. Keller, N. Solomon, J.C. Reid and D. Mazola (Columbia, MO and Boston, MA, U.S.A.) The influence of mania and depression on the pharmacokinetics of lithium - A longitudinal single-case study by A. Kukopulos. C. Minnai and B. Mtiller-Oerlinghausen (Rome and Cagliari. Italy and Berlin, F.R.G.) Assessment of depression by questionnaire compared to DSM-III diagnosis by V. Carr and J. Smith (Adelaide, SA. Australia) Drug response as a predictor of transmission of non-bipolar maJor depression within families by B.A. Prusoff, M.M. Weissman. K.R. Merikangas, J.F. Leckman and K.K. Kidd (New Haven, CT, U.S.A.) Neuroticism and personality disorder in depression by J. Davidson, R. Miller and R. Strickland (Durham, NC and Madison, WI. U.S.A.) Imipramine metabolism in recurrent depressive episodes by G. Tollefson. R. Valentine, M. Garvey and V.B. Tuason (St. Paul. MN, U.S.A.)
Short Communicatmns Family history of suicide in manic-depressive patients by A. Roy (Bethesda, ,MD, U.S.A.) A relationship between prolactin levels and Dexamethasone Suppression Test results in major depressive by P.R. Joyce, R.A. Donald and J.H. Livesey (Christchurch, New Zealand) L-5-Hydroxytryptophan in the treatment of anxiety disorders by R.S. Kahn and H.G.M. Westenberg (Utrecht, The Netherlands) Announcement
147-151 1533157 1599166 1677170 171-176 177-182 183-186
187-189 disorder 191-195 197-200
._..__.,__......................................................._.._.....
No. 3 - May/June
137-145
201
1985 Papers presented
at the British Association
for Psychopharmacology
Symposium
on
PSYCHOPHARMACOLOGYOF MANIA
(London,
U.K., 8 June, 1984)
Editorial by ES. Paykel and G. Winokur (London, U.K. and Iowa, IA, U.S.A.) The diagnosis of mania by R.E. Kendell (Edinburgh, U.K.) . The neurochemistry of mania - The effect of lithium on catecholamines, indoleamines and calcium by K. Wood (Epsom. Surrey, U.K.) . . Dopamine in manic depressive illness - A pharmacological synthesis by T. Silverstone (London, U.K.). . . The neuroendocrinology of mania byJ.C.Cookson(London,U.K.)........................................................ The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders by H.M. Emrich, M. Dose and D. von Zerssen (Munich, F.R.G.) . Lithium in the treatment of mania by S.P. Tyrer (Newcastle upon Tyne, U.K.) Lithium prophylaxis of recurrent affective disorders by A.I.M. Glen (Inverness, Scotland, U.K.)
205 207-213 mobilization 215-223
.
225-231 233-241
.
243-250 251-257
.
259-265
End of the Symposium
Research Papers The TRH stimulation test and reverse Ta in depression by H.A. Sternbach, HE. Gwirtsman, R.H. Gerner, J. Hershman and E. Pekary (Los Angeles, CA, Bethesda, Irvine,CA,andLongBeach,CA,U.S.A.) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .._.._........._..
MD, 267-270
298 Spontaneous afternoon plasma cortisol in depression by P. Christensen, L.F. Gram, P. Kragh-Sorensen. L. Christensen, Thomsen (Odense, Denmark) Inter-rater reliability of the Italian version of the Paykel Scale of Stressful by S. Baratta, C. Colorio and Ch. Zimmermann-Tansella (Verona, Italy) Diagnosis in school-age children of bipolar affective disorder patients and by E.S. Gershon. D. McKnew, L. Cytryn, J. Hamovit, J. Schreiber, E. Washington. DC. U.S.A.) Announcement
..__..__..._..__._._.._.._..______.._......,._____._._..__.____.._.......
Author Index (Vol. 8) T&e
ofContents (Vol. 8)
C.B. Kristensen.
O.L.
Pedersen
and
H.Y. 271-278
Life Events 279-282 normal controls Higgs and D. Pellegrini
(Bethesda.
MD and 2X3-291 293 294-295 296-298
296
Dr.wrder.r. 8
(1985)296-298 Elsevier
Table of Contents (Vol. 8)
No. 1 - January/February Research
1985
Papers
Self-reported diurnal mood changes, early morning awakening and the Dexamethaaone Suppression Test in endogenous depression by L. Grunhaus. P. Flegel, B.J. Carroll and J.F. Greden (Ann Arbor, MI and Durham. NC, U.S.A.) Difficulty of follow-up and posttreatment functioning among depressed patients by A.G. Billings, R.C. Cronkite and R.H. Moos (Palo Alto, CA, U.S.A.) Bipolar II - Combine or keep separate? by J. Endicott, J. Nee, N. Andreasen, P. Clayton. M. Keller and W. Coryell (New York, NY. U.S.A.) A controlled study of a specific MAO A reversible inhibitor (Roll-1163) and amitriptyline in depressive illness by T.R. Norman. D. Ames, G.D. Burrowzs and B. Davies (Heidelberg and Parkville. Vie., Australia) Four definitions of endogenous depression and the Dexamethasone Suppression Test by M. Zimmerman, W. Coryell, B. Pfohl and D. Stangl (Iowa City. IA, U.S.A.) Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients by S.A. Simmons. P.J. Perry. E.D. Rickert and J.L. Browne (Iowa City. IA, U.S.A.) Vasoactive intestinal peptide and bipolar affective illness ~ Evidence for an effect of lithium by W.H. Berrettini, J.I. Nurnberger, P. Hotvedt, S. Simmons-Alhng and ES. Gershon (Bethesda. MD and Middlebury,VT, U.S.A.) Sleep of atypical depressives by F.M. Quitkin. J.G. Rabkin. J.W. Stewart. P.J. McGrath. W. Harrison, M. Davies, R. Goetz and J. Puig-Antich (New York. NY, U.S.A.) Apparent supersensitivity of platelet 5-HT receptors in lithium-treated patients by K. Wood. C. Swade. M.T. Abou-Saleh and A. Coppen (Epsom, U.K.) Psychosocial predictors of outcome in subjects with untreated depressive disorder by G. Parker and I. Blignault (Little Bay, NSW, Australia) The Dexamethasone Suppression Test and depressive signs in dementia by C.L.E. Katona and C.R. Adridge (London, U.K.) Reversal of vanadate-induced inhibition of Na-K ATPase ~ A possible explanation of the therapeutic effect of carbamazepine in affective illness byG.J.Naylor(Dundee,U.K.) _. _. _. _. _. The Dexamethasone Suppression Test in depression by H. Dam, E.T. Mellerup and O.J. Rafaelsen (Copenhagen, Denmark)
I-
7
Y-~ 16
17-
28
2Y- 35 37-
45
47-
53
5%
59
61-
67
69-
72
73-
Xl
x3-
89
91-
93
955103 105
No. 2 - March/April Research
1985
Paper.7
The
Dexamethasone Suppression Test in schizo-affective depression by C.L.E. Katona and M. Roth (London and Cambridge, U.K.) Mania - Diagnosis, state measurement and prediction of treatment response by S.K. Secunda. M.M. Katz, A. Swarm, S.H. Koslow, J.W. Maas. S. Chuang and J. Croughan (Springfield, Bethesda and Rockville, MD, Houston and San Antonio. TX. Chicago, IL and St. Louis. MO. U.S.A.) Plasma nortriptyline and clinical response in depression by G.E. Murphy, A.D. Simons and R.D. Wetzel (St. Louis, MO and Pittsburgh. PA, U.S.A.) Trace elements in manic depressive psychosis by G.J. Naylor, A.H.W. Smith, D. Bryce-Smith and N.1. Ward (Dundee. Reading and Ascot. U.K.) 0165-0327/85/$03.30
0 1985 Elsevier Science Publishers
B.V. (Biomedical
Division)
107-112 PA, 113-121 1233129 131-136
297 Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients - A trait finding by R.G. Kathol (Iowa City, IA, U.S.A.) . The Dexamethasone Suppression Test in delusional depression - Further findings by J.L. Ayuso-Gutierrez. M.I. Almoguera. E. Garcia-Camba, J. de1 Olmo Frias and J.A. Cabranes (Madrid, Spain) Double depression in adolescent substance users by J.H. Kashani. M.B. Keller, N. Solomon, J.C. Reid and D. Mazola (Columbia, MO and Boston, MA, U.S.A.) The influence of mania and depression on the pharmacokinetics of lithium - A longitudinal single-case study by A. Kukopulos. C. Minnai and B. Mtiller-Oerlinghausen (Rome and Cagliari. Italy and Berlin, F.R.G.) Assessment of depression by questionnaire compared to DSM-III diagnosis by V. Carr and J. Smith (Adelaide, SA. Australia) Drug response as a predictor of transmission of non-bipolar maJor depression within families by B.A. Prusoff, M.M. Weissman. K.R. Merikangas, J.F. Leckman and K.K. Kidd (New Haven, CT, U.S.A.) Neuroticism and personality disorder in depression by J. Davidson, R. Miller and R. Strickland (Durham, NC and Madison, WI. U.S.A.) Imipramine metabolism in recurrent depressive episodes by G. Tollefson. R. Valentine, M. Garvey and V.B. Tuason (St. Paul. MN, U.S.A.)
Short Communicatmns Family history of suicide in manic-depressive patients by A. Roy (Bethesda, ,MD, U.S.A.) A relationship between prolactin levels and Dexamethasone Suppression Test results in major depressive by P.R. Joyce, R.A. Donald and J.H. Livesey (Christchurch, New Zealand) L-5-Hydroxytryptophan in the treatment of anxiety disorders by R.S. Kahn and H.G.M. Westenberg (Utrecht, The Netherlands) Announcement
147-151 1533157 1599166 1677170 171-176 177-182 183-186
187-189 disorder 191-195 197-200
._..__.,__......................................................._.._.....
No. 3 - May/June
137-145
201
1985 Papers presented
at the British Association
for Psychopharmacology
Symposium
on
PSYCHOPHARMACOLOGYOF MANIA
(London,
U.K., 8 June, 1984)
Editorial by ES. Paykel and G. Winokur (London, U.K. and Iowa, IA, U.S.A.) The diagnosis of mania by R.E. Kendell (Edinburgh, U.K.) . The neurochemistry of mania - The effect of lithium on catecholamines, indoleamines and calcium by K. Wood (Epsom. Surrey, U.K.) . . Dopamine in manic depressive illness - A pharmacological synthesis by T. Silverstone (London, U.K.). . . The neuroendocrinology of mania byJ.C.Cookson(London,U.K.)........................................................ The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders by H.M. Emrich, M. Dose and D. von Zerssen (Munich, F.R.G.) . Lithium in the treatment of mania by S.P. Tyrer (Newcastle upon Tyne, U.K.) Lithium prophylaxis of recurrent affective disorders by A.I.M. Glen (Inverness, Scotland, U.K.)
205 207-213 mobilization 215-223
.
225-231 233-241
.
243-250 251-257
.
259-265
End of the Symposium
Research Papers The TRH stimulation test and reverse Ta in depression by H.A. Sternbach, HE. Gwirtsman, R.H. Gerner, J. Hershman and E. Pekary (Los Angeles, CA, Bethesda, Irvine,CA,andLongBeach,CA,U.S.A.) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .._.._........._..
MD, 267-270
298 Spontaneous afternoon plasma cortisol in depression by P. Christensen, L.F. Gram, P. Kragh-Sorensen. L. Christensen, Thomsen (Odense, Denmark) Inter-rater reliability of the Italian version of the Paykel Scale of Stressful by S. Baratta, C. Colorio and Ch. Zimmermann-Tansella (Verona, Italy) Diagnosis in school-age children of bipolar affective disorder patients and by E.S. Gershon. D. McKnew, L. Cytryn, J. Hamovit, J. Schreiber, E. Washington. DC. U.S.A.) Announcement
..__..__..._..__._._.._.._..______.._......,._____._._..__.____.._.......
Author Index (Vol. 8) T&e
ofContents (Vol. 8)
C.B. Kristensen.
O.L.
Pedersen
and
H.Y. 271-278
Life Events 279-282 normal controls Higgs and D. Pellegrini
(Bethesda.
MD and 2X3-291 293 294-295 296-298